Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

Summary

Study to compare once-daily extended release tacrolimus versus twice-daily immediate release tacrolimus following renal allograft failure to reduce the risk of allosensitisation

Timeline

Start

2018-11-01

Primary completion

2024-06-27

Completion

2025-02-25

Outcome

Outcome not reported

Stopped: “Non-feasible due to change in clinical practice”

Drugs

Indications